Thermo Fisher Boosts Diagnostics Portfolio
WALTHAM, Mass (
) --
Thermo Fisher Scientific
(TMO) - Get Report
signed a deal to acquire Germany's
Brahms
, a provider of in-vitro diagnostic tests for certain diseases, for 330 million euros ($471 million) in a bid to boost its specialty diagnostics portfolio.
Brahms, based outside Berlin, had 2008 revenue of about $105 million and employs about 400 workers. It has sales offices in Europe and the U.S.
Thermo Fisher said the deal is expected to add to earnings in 2010. The acquisition should close late this month.
"This acquisition reinforces our strategy of building on our leadership in niche specialty diagnostics markets," Thermo Fisher said in a statement Thursday.
-- Reported by Joseph Woelfel in New York
.
Follow TheStreet.com on
and become a fan on
